- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03305094
The Effect of Remote Ischemic Preconditioning in Aortic Valve Replacement Surgery
The Effect of Remote Ischemic Preconditioning in Aortic Valve Replacement Surgery : a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Quebec City, Quebec, Canada, G1V 4G5
- Hôpital Laval
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Planned isolated aortic valve replacement (stenosis based)
- Age ≥ 18 years
Exclusion Criteria:
- Pregnancy
- Left ventricular dysfunction (LVEF< 50%)
- Myocardial Infarct (< 7days)
- Coronary artery disease (documented with >50% stenosis)
- Coronary artery bypass grafting
- Chronic renal insufficiency (creatinine >175 mmol/L or dialysis)
- Endocarditis
- Sternotomy redo
- Deep vein thrombosis to the compressed limb
- Emergency procedure
- TAVI procedure
- Planned off pump coronary artery bypass
- MAZE procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
Sham remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 20 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg. The sham ischemia-reperfusion cycle is performed 3 times for a total of 30 min. This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass. A 20 mm Hg blood pressure cuff on the right arm does not induce ischemia. |
Cuff pressure for ischemia sham is 20 mm Hg, ischemia is 200 mm Hg and reperfusion is 0 mm Hg
|
Experimental: Intervention group
Remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 200 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg.
The ischemia-reperfusion cycle is performed 3 times for a total of 30 min.
This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass.
|
Cuff pressure for ischemia sham is 20 mm Hg, ischemia is 200 mm Hg and reperfusion is 0 mm Hg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in biochemical markers of myocardial ischemia
Time Frame: 6, 12, 24 and 48 hours post-operatively
|
Troponin T-HS and CK-MB concentration
|
6, 12, 24 and 48 hours post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative complications
Time Frame: post-operatively until 30 days
|
Monitoring the safety of the strategy by monitoring post-operative complications
|
post-operatively until 30 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CONDOR-21082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
The Medicines CompanyCompletedTranscatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic StenosisNetherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Hospices Civils de LyonRecruiting
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Edwards LifesciencesActive, not recruitingHeart Failure | Aortic Stenosis | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral StenosisUnited States, Canada, Poland
-
Edwards LifesciencesCompletedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Sorin Group USA, Inc.TerminatedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
Clinical Trials on Blood pressure cuff inflation
-
Lawson Health Research InstituteCompletedRaynaud Disease | Raynaud's PhenomenonCanada
-
Mayo ClinicCompleted
-
Mayo ClinicCompletedCoronary Artery IschemiaUnited States
-
Suez Canal UniversityUnknown
-
University Medicine GreifswaldWithdrawnIschemic Heart DiseaseGermany
-
Derek YellonCompletedIschemia | Covid19Brazil, South Africa, United Kingdom
-
Ramathibodi HospitalCompletedEndotracheal Cuff Pressure | Flow-Volume Loop Guided | Stethoscope-guidedThailand
-
Yonsei UniversityCompletedSurgical Complications From General AnesthesiaKorea, Republic of
-
University of AlbertaCompletedRemote Ischemic Preconditioning | Myocardial ProtectionCanada
-
University of LeicesterUniversity Hospitals, Leicester; Freemasons' Medical Research FundingCompletedPost Myocardial InfarctionUnited Kingdom